ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,466Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 1006

$599K Total Retail Price of All Prescriptions

Rank: 155 out of 1006

349 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 349 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 9,518 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 587 501 1 1
LEVOTHYROXINE SODIUM 425 416 2 2
WARFARIN SODIUM 388 388 3 8
ATORVASTATIN CALCIUM 356 319 4 5
FUROSEMIDE 323 299 5 6
LISINOPRIL 281 275 6 3
AMLODIPINE BESYLATE 278 263 7 4
METOPROLOL SUCCINATE 257 244 8 12
METFORMIN HCL 245 217 9 10
METOPROLOL TARTRATE 234 220 10 7
DONEPEZIL HCL 224 224 11 17
OMEPRAZOLE 220 189 12 9
MIRTAZAPINE 199 199 13 26
NAMENDA 186 175 14 34
GABAPENTIN 144 144 15 20
LOVASTATIN 128 128 16 44
TRIAMTERENE-HCTZ 122 121 17 58
LOSARTAN POTASSIUM 110 110 18 22
CYMBALTA 106 94 19 41
RAMIPRIL 102 93 20 79
LIDODERM 100 90 21 66
QUETIAPINE FUMARATE 100 100 21 45
ESCITALOPRAM OXALATE 98 89 23 27
SERTRALINE HCL 89 84 24 19
ATENOLOL 89 86 24 13
ENALAPRIL MALEATE 88 76 26 83
ALENDRONATE SODIUM 87 74 27 29
HYDROCHLOROTHIAZIDE 86 86 28 11
TRAZODONE HCL 85 67 29 21
RISPERIDONE 81 78 30 40
DILTIAZEM 24HR CD 81 81 30 88
POTASSIUM CHLORIDE 80 80 32 30
LIPITOR 79 79 33 47
TAMSULOSIN HCL 75 64 34 23
CRESTOR 72 72 35 18
ALLOPURINOL 71 71 36 31
OXYBUTYNIN CHLORIDE ER 70 70 37 92
CITALOPRAM HBR 69 53 38 24
DIOVAN 69 52 38 16
DIGOXIN 68 65 40 52
PREDNISONE 67 66 41 33
LACTULOSE 66 56 42 104
CLOPIDOGREL 66 59 42 46
PLAVIX 56 51 44 61
NITROGLYCERIN PATCH 55 55 45 160
CLOZAPINE 53 0 46 107
LABETALOL HCL 52 52 47 164
FLUTICASONE PROPIONATE 51 45 48 55
PAROXETINE HCL 51 21 48 62
AZITHROMYCIN 50 46 50 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.